Skip to Content

Hepatitis A Pediatric Vaccine Dosage

Medically reviewed on August 9, 2018.

Applies to the following strengths: 25 units/0.5 mL; 720 units/0.5 mL; 720 units/0.5 mL preservative free

Usual Pediatric Dose for Hepatitis A Prophylaxis

1 year and older: 0.5 mL intramuscularly
-Administer a booster 0.5 mL dose 6 to 18 months after the first dose

Comments:
-Administer in the deltoid region in children 2 years and older.
-Administer in the anterolateral aspect of the thigh in younger children.

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Precautions

CONTRAINDICATIONS:
-Hypersensitivity to any of the ingredients including neomycin
-Hypersensitivity to previous hepatitis A vaccination

Safety and efficacy have not been established in patients younger than 1 year.

To report suspected adverse reactions, contact the Vaccine Adverse Event Reporting System (VAERS) at: https://vaers.hhs.gov

Consult WARNINGS section for additional precautions.

Dialysis

Data not available.

Other Comments

Administration advice:
-For intramuscular use only.
-Do not administer in the gluteal area as a suboptimal response may occur.
-Do not administer intravenously, intradermally, or subcutaneously.
-Primary immunization should be given at least 2 weeks prior to expected exposure to hepatitis A.

Storage requirements:
-Refrigerate; do not freeze

Reconstitution/preparation techniques:
-Shake well before use.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide